Literature DB >> 2715721

Inhibition of lipid transfer by a unique high density lipoprotein subclass containing an inhibitor protein.

T Nishide1, J H Tollefson, J J Albers.   

Abstract

We have isolated from human plasma a unique subclass of the high density lipoproteins (HDL) which contains a potent lipid transfer inhibitor protein (LTIP) that inhibited cholesteryl ester, triglyceride, and phospholipid transfer mediated by the lipid transfer protein, LTP-I, and phospholipid transfer mediated by the phospholipid transfer protein, LTP-II. This HDL subclass not only inhibited cholesteryl ester transfer from HDL to LDL or VLDL, but also inhibited cholesteryl ester transfer from HDL to HDL. The inhibitor protein was isolated by sequential chromatography of human whole plasma on dextran sulfate-cellulose, phenyl-Sepharose, and chromatofocusing chromatography. Isolated LTIP had the following characteristics: an apparent molecular weight of 29,000 +/- 1,000, (n = 10) by sodium dodecyl sulfate gel electrophoresis, and an isoelectric point of 4.6 as determined by chromatofocusing. LTIP remained functional following delipidation with organic solvents. Antibody to LTIP was produced, and an immunoaffinity column of the anti-LTIP was prepared. Passage of human, rat, or pig whole plasma over the anti-LTIP column enhanced cholesteryl ester transfer activity in human (17%), pig (200%), and rat plasma (125%). The HDL subclass containing LTIP was isolated from whole human HDL (d 1.063-1.21 g/ml) by immunoaffinity chromatography. The isolated LTIP-HDL complex was shown to: i) contain about 60% protein and 40% lipid, ii) have alpha and pre-beta electrophoretic mobility, iii) have particle size distribution somewhat smaller than whole HDL, about 100,000 daltons, as determined by gradient gel electrophoresis, and iv) contain only a small amount of apoA-I (less than 5%) and a trace amount of apoA-II. Assay of ultracentrifugally obtained lipoprotein fractions revealed that approximately 85% of the total functional LTIP activity was in the d 1.063-1.21 g/ml HDL fraction. Furthermore, immunoblot analysis of whole plasma by nondenaturing gradient gel electrophoresis revealed that LTIP was found predominantly in particles in the size range of HDL. This unique HDL subclass may play an important role in the regulation of plasma lipid transfer and metabolism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715721

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

Review 1.  Interaction of lipid transfer protein with plasma lipoproteins and cell membranes.

Authors:  R E Morton
Journal:  Experientia       Date:  1990-06-15

Review 2.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

3.  Conformational studies of the N-terminal lipid-associating domain of human apolipoprotein C-I by CD and 1H NMR spectroscopy.

Authors:  A Rozek; G W Buchko; P Kanda; R J Cushley
Journal:  Protein Sci       Date:  1997-09       Impact factor: 6.725

4.  Structural studies of a baboon (Papio sp.) plasma protein inhibitor of cholesteryl ester transferase.

Authors:  G W Buchko; A Rozek; P Kanda; M A Kennedy; R J Cushley
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

5.  Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland.

Authors:  Kaijin Wu; Corrine Joffre; Xiaodong Li; Michelle MacVeigh-Aloni; Melinda Hom; Juliana Hwang; Chuanqing Ding; Stephane Gregoire; Lionel Bretillon; Jiang F Zhong; Sarah F Hamm-Alvarez
Journal:  Exp Eye Res       Date:  2009-04-02       Impact factor: 3.467

6.  Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo.

Authors:  William R Lagor; Robert J Brown; Sue-Anne Toh; John S Millar; Ilia V Fuki; Margarita de la Llera-Moya; Tiffany Yuen; George Rothblat; Jeffrey T Billheimer; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-13       Impact factor: 8.311

7.  The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice.

Authors:  William R Lagor; David W Fields; Sumeet A Khetarpal; Arthi Kumaravel; Wen Lin; Nathaniel Weintraub; Kaijin Wu; Sarah F Hamm-Alvarez; Denise Drazul-Schrader; Margarita de la Llera-Moya; George H Rothblat; Daniel J Rader
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

8.  Effect of Synthetic Truncated Apolipoprotein C-I Peptide on Plasma Lipoprotein Cholesterol in Nonhuman Primates.

Authors:  Rampratap S Kushwaha; Henry C McGill; Frederick H Hausheer
Journal:  J Biomed Biotechnol       Date:  2004
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.